Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,107 public trials 145 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

NCT04176198

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
View all 84 locations
View Trial Details
Recruiting

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

NCT04116502

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Belfast City Hospital Belfast, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
View all 47 locations
View Trial Details
Recruiting

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

NCT06514534

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
Locations
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Lille, France
  • Novartis Investigative Site Lyon, France
  • Novartis Investigative Site Nantes, France
View Trial Details
Recruiting

Asciminib RMP Study

NCT05943522

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Wŏnju, Gangwon-do, South Korea
  • Novartis Investigative Site Anyang-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Bucheon-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Uijeongbu-si, Gyeonggi-do, South Korea
View all 17 locations
View Trial Details
Recruiting

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

NCT06517875

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • GSK Investigational Site Ann Arbor, Michigan, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Nashville, Tennessee, United States
  • GSK Investigational Site Houston, Texas, United States
View all 33 locations
View Trial Details

Related conditions